since birth, however, any intrinsic age-study population and the epidemiology of the malarial infections observed throughout dependent factors aVecting the onset of clinical immunity are obscured. Only in pre-the study period. viously unexposed populations of all ages that have been abruptly and permanently exposed to endemic malaria can the eVects SUBJECTS AND METHODS of age and cumulative exposure to infection be separated. When Baird et al. (1991b, Study Site A newly constructed village, designated 1993) conducted cross-sectional studies in such populations, they found evidence of the Satuan Permukiman (Settlement Unit) 2 (SP2)
by the Indonesian Department of Transage-dependent onset of clinical immunity despite apparently equal cumulative exposure migration, served as the study site. SP2 was located at Armopa (139°32¾E, 21°6¾S) in to infection among all age-groups.
The possibility that the onset of clinical the Bonggo sub-district of Jayapura district in north-eastern Papua (formerly known as immunity to P. falciparum is age-dependent, and not dependent on chronic, cumulative Irian Jaya), Indonesia. Housing was of uniform, wood-plank and tin-roof construction, exposure (Baird, 1995 (Baird, , 1998 , clearly has implications for those attempting to develop and laid out in a grid pattern. The village was completed, in an area of about 4 km 2 vaccines to diminish the burden of disease and death caused by P. falciparum. The con-cleared of dense, lowland tropical rainforest and located within 2 km of the Paci c Ocean, ventional logic underlying vaccine development is that disease can be prevented by shortly before the rst migrants arrived in August 1996. It was fully occupied, with increasing exposure to protective antigens. The development of a malaria vaccine, for 1551 residents living in 450 homes, by October 1996. The resident families had example, hinges largely upon strategies to provide suYcient exposure to the surface mostly migrated from East (180 families), Central (97) or West Java (128), although antigens of P. falciparum or other Plasmodium spp. (Good et al., 1998; Plebanski and Hill, 45 families were native to Papua. The new villagers soon established cash and subsistence 2000). However, susceptibility to infection and disease may be a consequence not of crops, primarily of soy, peanut, cassava, melon, papaya and maize. insuYcient exposure to antigen but of an inappropriate immune response driven prePerennial transmission of malariaprimarily P. falciparum and P. vivax but dominantly by intrinsic factors related to age. If so, the induction of an immune also P. malariae and P. ovale -occurs in north-eastern Papua (Baird et al., 1990 ; response in infants and small children that provides adult-like protection from disease Jones et al., 1994) . Members of the Anopheles punctulatus group are the overwhelmingly may require the manipulation of the intrinsic age-related character of the immune response dominant vectors of the region (Metselaar, 1961) . Most species in this group are widely to chronic exposure.
In the present study, Javanese subjects were dispersed and show niche-speci c habitat preferences, their distributions often being followed for 33 months after they migrated to a malaria-endemic region of Indonesian increased by forest clearing and the establishment of new settlements (SlooV, 1964) . The Papua. The main aim was to explore the ageand exposure-related determinants of the likely sources of malaria in new Papuan villages settled entirely by malaria-naṏve onset of clinical immunity to P. falciparum malaria. This report, the rst in a series migrants are, initially, infected workers constructing the villages and, after occupation, from this cohort, describes the methods of recruitment, enrolment and follow-up, residents arriving from endemic areas and/or visitors from neighbouring Papuan villages. along with the demographic features of the There is no known occupational risk factor arrived. The nets were plentiful, freely availfor exposure to the vector mosquitoes in the able and very often used by all members of Armopa area, and such mosquitoes exhibit the household, net use being encouraged by no marked preference for adults (compared an abundance of pest insects, rodents and with children) when blood-seeking, beyond venomous snakes. Apart from the bed nets, that attributable to the greater surface area the housing oVered no barriers to mosquitoes, of adults (Burkot, 1988; insect-repellent lotions were not widely 1989, 1998) .
available. Each evening, most residents of SP2 put on clothing that covered their arms and legs, to minimize mosquito biting. Subjects Groups of approximately 25 families each arrived at SP2 en masse within a day or two Follow-Up of having been own, on chartered airplanes,
The research team established a clinic in from Java to Papua (arriving at Sentani air-SP2 staVed with a physician, nurse and a port, near Jayapura). On the day of their team of laboratory specialists and assistants. arrival, the newcomers were screened for
The clinic was the primary source of health their suitability for enrolment in the present care for all residents of SP2. All residents study. Most were screened at Sentani airhad free access to the clinic without regard port, and the others were screened within to enrolment status. Full-time paid assistants a day of their arrival at SP2. To be enrolled, were hired from SP2 and trained to conduct a migrant had to be aged 6-12 or "20 the routine follow-up procedures and preyears, to have no history of residence in a pare bloodsmears. These 'health workers' malarious area in the previous 5 years, to be visited each subject in his or her home three bloodsmear-negative for malarial parasites, times/week, to see if the subjects were in to have no splenomegaly, to be in good good health. Subjects appearing ill or comgeneral health, and give a normal result in a plaining of illness in response to a standardized test for glucose-6-phosphate-dehydrogenase question (i.e. 'Do you have any symptoms?') (G6PD) de ciency. All of the eligible were referred to the study physician for volunteers or their guardians provided written evaluation and bloodsmear examination. Any informed consent and all of those enrolled complaint of illness prompted a bloodsmear were assigned study-subject identi cation examination, and the subject was considered codes.
to have symptomatic malaria if found smearTo ensure the treatment of the subjects positive. Smear-positive subjects with at least was ethical, a protocol detailing the conduct one symptom attributable to malaria were of this study was reviewed and approved treated promptly (see below) and began a by the institutional review boards of the post-infection follow-up consisting of the United States Navy and Indonesian Ministry collection of a sample of venous blood on of Health. Moreover, all of the work was the rst day of treatment (day 0) and day performed in accordance with the relevant 28, and the preparation of bloodsmears on regulations governing the use of such subdays 0, 2, 4, 11, 14, 18, 21, 28, 35 and 42 . jects -those of the Indonesian Ministry Routine bloodsmears prepared every 2 of Health, and United States government weeks were stained, stored and later examined (code 32 of Federal Regulation, Part 219, in a laboratory in Jakarta. Blood and plasma Protection of Human Subjects; U.S. Navy, were collected from all subjects every 2 SECNAVINST 3900.39B).
months. Twice a year, each subject was Local authorities provided bednets (without insecticide) to all of the residents as they given a physical examination that included measurement of spleen size, body weight, this period prompted therapy with generic quinine (Kimia Farma), given at 10 mg/kg height and middle-upper-arm circumference three times daily for 7 days. and a complete blood cell count on a QBC Subjects meeting the World Health counter (BD, Franklin Lakes, NJ ). This Organization's criteria for severe P. falciparum regimen of follow-up began on the day of malaria (WHO, 2000) were treated with arrival and enrolment in August-October intravenous quinine in a standard protocol: 1996 and ended in July 1999, when the generic quinine dihydrochloride (Kimia study ceased.
Farma) at 20 mg salt/kg in 5% dextrose saline as a 4-h loading dose, followed 4 h later, with 10 mg salt/kg over another 4 h, Treatment of Malaria repeated every 8 h until the subject was As prophylaxis, all those who had just moved capable of taking oral medication. to SP2 received a supervised weekly dose Subjects diagnosed with P. vivax malaria of 5 mg chloroquine base/kg for a period were not only treated with chloroquine of 90 days, in accordance with the policy of or me oquine according to assignment (as the Indonesian Ministries of Health and above) but also received 15 mg primaquine Transmigration. Although this regimen is daily for 14 days. ineVective in preventing parasitaemias caused Pre-treatment, all women with symptoby P. falciparum or P. vivax (Baird et al., matic P. falciparum malaria were tested 1995; FryauV et al., 1995) , it may reduce for pregnancy using a urine dipstick for the risk of severe disease and death during human chorionic gonadotropin; those found the 90 days of prophylaxis. On the day of positive received me oquine regardless of enrolment, the subjects were randomized to their treatment assignment. either chloroquine-or me oquine-treatment A physician evaluated each subject who groups. Treatment of uncomplicated, slide-required therapy and recorded axillary temcon rmed P. falciparum malaria during the perature and all the physical complaints 33 months of follow-up was consistent accord-reported by the subject, at presentation in ing to this assignment for each subject: the clinic. The results of clinical trials in the directly observed chloroquine (Resochin ; region demonstrated a 28-day cumulative risk P.T. Bayer Indonesia, Jakarta), as doses of of chloroquine-treatment failure of approxi-10, 10 and 5 mg base/kg at 24-h intervals, mately 80% for P. falciparum and 70% for or me oquine (Lariam ; HoVman-La Roche, P. vivax (Baird et al., 1991a (Baird et al., , 1997 . Basel), as a single dose of 15 mg base/kg.
At 6-month intervals, as a crude gauge of This approach addressed the hypothesis that risk of infection among the study subjects, a curative drug (me oquine) would inhibit homes in SP2 were visited at random and or delay the onset of acquired immunity occupants aged >5 years who were not more than a primarily suppressive drug already enrolled in the present study were (chloroquine).
asked if ngerprick samples of blood might The occurrence of a recurrent P. falciparum be collected from them. Smears of the parasitaemia within 28 days of the rst blood samples so collected allowed a crosstreatment dose (on day 0) was considered sectional exploration of the prevalence and a therapeutic failure and prompted the density of parasitaemia among the SP2 supervised administration of a single dose of residents. sulfadoxine-pyrimethamine (Kimia Farma,
The availability of antimalarial drugs outBandung, Indonesia) equivalent to 25 mg side of the clinic operated by the research sulfadoxine and 1.25 mg pyrimethamine/kg, team was very limited. The village was and a second round of 42 days of post-extremely isolated from market places by distance, a poor road, and an incomplete therapeutic monitoring. Recurrence during bridge over a large river. In other words, Entomology drugs through the research clinic were Mosquito and climate surveillance began in nearby and free, whereas those in the market late August 1996 and lasted until June 1999. places were far away and relatively expensive. During the study period, the local health Unsupervised therapy was therefore unlikely authorities conducted three spray rounds to have been a serious potential confounder with a residual insecticide: two (in August in the study cohort.
1996 and March 1997) with bendiocarb and one (in February 1998) with lambdacyhalothrin. Routine, all-night, humanClassi cation of Infection landing collections (HLC) were conducted Each parasitaemia detected was classi ed as weekly to estimate human contact rates, a new infection or a recrudescence simply vector activity patterns and sporozoite on the basis of the length of time since the infection 'rates'. Four sentinel HLC houses patient had last been parasitaemic, only a were selected to derive human-landing rates parasitaemia that occurred within 28 days of (HLR; i.e. the number of mosquitoes a previous parasitaemia being considered a captured/person-evening). The HLR were recrudescence. The results of examining the based on the results of twice-weekly, 12-h bloodsmears prepared routinely every 2 weeks collections (from approximately 18.00-06.00 sometimes revealed a parasitaemia in a hours). Mosquitoes were collected, for 50 min subject who, though not on chemotherapy, in each collection hour, from the exposed had not complained of any symptoms and legs of a trained technician, using a mouth was afebrile when (and remained afebrile aspirator and ashlight. Captured mosquitoes for "24 h after) the blood sample had been were placed in collection cups each hour. At collected. Such parasitaemias were included the study site, Anopheles mosquitoes were in the process of assigning infection sequence sorted, identi ed by species, and stored dry, during the 33 months of follow-up. An over silica gel, until assayed for Plasmodium ordered sequence of species-speci c (i.e. infection in the laboratory in Jakarta. P. falciparum or P. vivax) new infections was Individual mosquitoes were tested, in an therefore determined for each subject. New ELISA (Wirtz et al., 1987) , for the circuminfections were further classi ed as febrile or sporozoite proteins (CSP) of P. falciparum afebrile, according to the clinical records for and two P. vivax variants (Pv210 and Pv247). the day of therapy and/or blood collection.
Daily rainfall and maximum/minimum ambient temperatures were recorded on site throughout the study. Microscopy The microscopical demonstration of asexual malarial parasites in Giemsa-stained thick Statistical Analysis smears supported all diagnoses of malaria.
Results were expressed as means or freThe locally hired, eld-based microscopists, quencies and analysed using unpaired all of whom had more than 7 years' experiStudent's t-tests, or Mantel-Haenszel tests. ence of checking bloodsmears, were examined Fisher's exact tests were used when expected and certi ed competent. Only if no paracell values were below 5.0. A P-value of sites had been detected in 200 elds at a å0.05 was considered indicative of statistical magni cation of ×1000 was a thick smear signi cance. All the analyses were carried considered negative. Levels of parasitaemia out using version 9.0 of the SPSS (SPSS (asexual parasites/ml ) were estimated by Inc., Chicago, IL) or version 6.0 of the counting asexual parasites against 200 leucoEpi Info (Centers for Disease Control and cytes in thick smear and assuming each subject had 8000 leucocytes/ml. Prevention, Atlanta, GA) software packages. RESULTS areas and were dropped from the study. The remaining 146 adults and 97 children were considered the complete cohort. Of these Screening, Enrolment, and Withdrawal 243 subjects, 213 (88%) remained in the study after the rst year, 168 (69%) after Screening and enrolment typically occurred as groups of 10-40 families arrived en masse. the second year, and 159 (65%) when the study terminated in July 1999 (Table 2 ). Eleven such groups were screened between 25 August 1996 and 3 October 1996. Virtually all of the withdrawals (68 of 84)
were the result of families electing to return Screening against people likely to have a history of exposure to malaria produced 16 to Java. exclusions among the 322 interviewed and examined. Prior residence in a malarious area (16) was the commonest reason among the Prevalence of Parasitaemia in SP2
Although the rst of the 6-monthly, total of 61 exclusions. Overall, 159 adults (aged "20 years) and 102 children (aged cross-sectional examinations of bloodsmears covered just 13% of the population (samples 6-12 years) were enrolled in the study; 131 randomized to the chloroquine-and 130 to collected from 163 villagers), all the subsequent prevalence samples consisted of the me oquine-treatment group. Figure 1 illustrates the ow of subjects at screening, 20%-23% of the population of SP2 (i.e.
200-268 villagers). Figure 2 illustrates the enrolment and study conclusion, and Table 1 lists the demographic features of the cohort prevalences of P. falciparum and P. vivax infection among children (i.e. the subat enrolment.
Within a few days of enrolment, 13 of jects aged 6-12 years) and adults in SP2 over the period of study. Each age-speci c the adult subjects and ve of the children admitted a history of residence in malarious point represents a sample of between 18 and FIG. 1. Flowchart showing the number of subjects available for screening, at enrolment and up to the study conclusion. Those with glucose-6-phosphate-dehydrogenase de ciency could not be excluded prior to randomization because it took several days to test for this de ciency. Figure 3 illustrates the numbers of new prevalence of malarial infection diminished sharply between the rst cross-sectional infections by P. falciparum or P. vivax detected among the child and adult subjects survey (at month 6) and the last (at month 33), among both children and adults. There over the 33 months of the study. A total of 596 infections by P. falciparum occurred was no signi cant diVerence in the prevalences of P. falciparum and P. vivax in the cohort (255 among children and 341 among adults), and 22 subjects (nine infection except among the adults in the rst sample, who were much more likely to be children and 13 adults) each experienced at least six infections by P. falciparum. A total infected with P. vivax than P. falciparum (27.5% v. 14.5%; P=0.043).
residents (median sample=48). The Number of Infections
of 723 infections by P. vivax occurred in FIG. 3 . The numbers of adult (h ) and child (j ) subjects in the SP2 longitudinal cohort experiencing one to more than nine infections with Plasmodium falciparum or P. vivax.
the cohort (308 among children and 415 1.7 P. vivax infections/adult. In the third year, the annual incidence was 0.5 P. falciparum among adults), 27 subjects (14 children and 13 adults) each experiencing at least six and 0.5 P. vivax infection/child and 0.7 P. falciparum and 0.7 P. vivax infection/ infections with this species.
adult. Overall, the annual incidences of malarial infection (either P. falciparum or Incidence of Patent Infection P. vivax) during the rst, second and third Figure 4 illustrates the annual incidences years were 3.2, 2.7 and 1.2 infections/ of new infections with P. falciparum and subject-year, respectively. P. vivax among the subjects enrolled in the study. There were approximately 1.5 P. falciparum and 1.8 P. vivax infections/ Mean Parasite Counts Figure 5 illustrates the geometric mean parasubject (among both children and adults) in the rst year. In the second year, there site counts (GMPC) for P. falciparum and P. vivax for children and adults. Between were 1.2 P. falciparum and 1.4 P. vivax infections/child, and 1.3 P. falciparum and the rst and third years, the annual GMPC P. falciparum were higher in the children than in the adults over the rst (1796 v. 935 parasites/ml; P=0.002) and third years (2949 v. 1066 parasites/ml; P=0.03) but not over the second year (1655 v. 1345 parasites/ml; P >0.05). The corresponding counts for P. vivax were similar among the children and adults during the rst year (581 v. 448 parasites/ml; P =0.14) but signicantly higher in the children than in the adults during both the second (763 v. 384 parasites/ml; P <0.001) and third years (1067 v. 299 parasites/ml; P<0.001). slide-proven P. falciparum malaria. Six of these 22 cases were children and three (all children) died.
Severe Malaria
Among the other nine cases of severe malaria -eight adults and one child, who were all enrolled on the study and all of whom survived -one appeared smearpositive for P. vivax only and the rest smear-positive for P. falciparum. The severe episode of P. vivax malaria occurred with the rst infection whereas the severe attacks of P. falciparum malaria occurred with the rst (two cases), third (four) or fourth infections (two). The odds ratio for a P. falciparum infection developing into severe malaria in an adult subject, compared with that in a child, was 6.1 ( P=0.08). (a sibling species) were identi ed in collections (935 v. 1066 parasites/ml; P =0.66) showed no signi cant change. The GMPC for from inside and outside the sentinel homes.
For the purpose of data analysis and the DISCUSSION ELISA, both sibling species of An. farauti were grouped together (as An. farauti s.l.). The incidence of infection by P. falciparum The predominant species encountered was in the study cohort was approximately 1.5 An. punctulatus, followed by An. farauti s.l. infections/person-year during the rst 2 Vector biting rates typically increased during years, and just 0.6 infection/person-year in and immediately after the wet months of the third year. Most subjects experienced the year (November-March) and decreased only three or four infections with this parato far lower levels during the drier months site during the study. The incidence of (May-October; see Figure 6 ). In early 1998, P. falciparum infection in the Armopa region indoor and outdoor anopheline biting densities was also relatively low (Baird et al., 2001) declined markedly, and remained relatively but that observed in the Arso region, where low until the end of the study. the original cross-sectional studies of Javanese Between April and May 1997, a 97% transmigrants were conducted (Baird et al., reduction in the HLR was recorded. This 1991b , 1993 , was much higher. The results was attributed to the second round of indoor of longitudinal studies of malaria attack in spraying with bendiocarb, in late March the Arso region typically indicated an annual 1997. The total number of anophelines incidence of two to four P. falciparum captured in 1998-1999 was >84% lower infections/person ( Jones et al., 1994; Ohrt than the number caught in 1996 Ohrt than the number caught in -1997 Ohrt than the number caught in . A et al., 1997 Taylor et al., 1999) . Infection sustained, general suppression in mosquito incidence is a critical issue to those exploring population densities continued into 1998 the onset of clinical immunity to P. falciparum, and 1999, with only small adult-activity peaks because the attack rates in Arso and Armopa seen during the wet months of September-and the results of repeated challenge of neuroOctober 1998 and February-April 1999. The syphilis patients with P. falciparum (Ciuca ELISA-based estimates of the combined et al., 1934) indicate that such immunity indoor/outdoor sporozoite 'rates' remained may require at least four infections within 12-24 months (Baird et al., 2003) . Unlike around 0.2% throughout the study period. FIG. 6 . The monthly mean levels of anopheline-mosquito biting in SP2 over the course of the longitudinal study. those who live in the Arso region, relatively and adults; the incidence of infection by few residents of SP2 would have experienced P. falciparum in the SP2 cohort over 33 such exposure during the period of the pre-months was 1.11 infections/child-year and sent study. This diVerence may explain why, 1.10/adult-year. A similar analysis restricted after more than 2 years of exposure, the to rst infections also showed virtually prevalence of P. falciparum parasitaemia identical risk for the children and adults among the children investigated in SP2 was (Barcus et al., 2003) . Baird et al. (1991b) similar to that in the adults (Fig. 2) whereas thought that the risk of infection (i.e. sporoin Arso the adults were much less likely zoite inoculation) in Arso was probably to be parasitaemic than the children (Baird similar for children and adults because the et al., 1991b, 1993) . main local vectors tend to breed near to Several key factors probably explain the houses and to blood-feed predominantly relatively low risk of infection in SP2 com-around homes at night (SlooV, 1964; pared with that in the Arso region. There is 1988; Burkot et al., 1989) . That the preclearly an ethical responsibility to execute a valence of parasitaemia during early exposure programme of close surveillance and prompt to risk appeared to be unaVected by subject treatment among a cohort of essentially non-age supported that view (Baird et al., 1993) . immune subjects exposed to a potentially The diVerences in susceptibility to infection life-threatening infection. Application of such and disease observed between children and a strategy in SP2 almost certainly curtailed adult migrants have therefore been attributed the pool of infectious people and thereby to age-related diVerences in immune response arti cially reduced the incidence of infection. rather than to diVerences in cumulative Indeed, over the course of the study, sharp experience with infection (Baird et al., 1991b , drops in the prevalence of parasitaemia in 1993; Baird, 1995 Baird, , 1998 . The results of the village and in the incidence of infection the research in SP2 con rm that, in rural, among the study subjects were observed. north-eastern Indonesian Papua, the risk of Also, the numbers of biting anophelines exposure to infection in children is practically sharply declined following a routine, indoor the same as that in adults. application of a residual insecticide throughSevere disease rarely occurred in the out the village. Finally, an important dis-SP2 cohort. Only nine of the study subtinction between the habitat of the Arso jects required intravenous quinine over the study sites and those in Armopa is the 33-month study period. This contrasts with amount of cleared versus forested land; a new the situation in villages lacking the active palm-oil plantation dominated the habitat surveillance and prompt therapy aVorded to surrounding the Arso sites whereas virgin the study subjects. During the rst 2 years forest surrounded the Armopa study sites.
at Arso PIR IV, for example, the monthly This may be the most important factor incidence of severe malaria requiring evacubecause only at the one study site in the ation to hospital, among the adult Javanese Arso region that was surrounded by forest migrants, was typically 0.5 case/person-year rather than palm-oil plantation was the and peaked at 1.4 cases/person-year during annual incidence of P. falciparum infection the rst 6 months (Baird et al., 1998) . In found to be as low (1.1 infections/person; SP2, the eight cases of P. falciparum malaria FryauV et al., 1995) as those recorded in the who required intravenous quinine (also preArmopa region, either in SP2 (1.1/person; dominantly adult subjects) represented a present study) or elsewhere (0.9/person; corresponding incidence of only 0.01 case/ Baird et al., 2001) .
person-year. In other words, subjects in the The present results indicate that, in cohort at SP2 were at least 50 times less SP2 over the study period, the risk of patent infection was similar for the children likely to develop severe disease than similar
